Healthcare provider profile · identity verified

Robert Charles Dicintio, PA-C

Physician Assistant · EL RENO, OK · NPI 1811085178

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	583	147
Amlodipine Besylate	Amlodipine Besylate	446	90
Levothyroxine Sodium	Levothyroxine Sodium	434	89
Gabapentin	Gabapentin	325	60
Lisinopril	Lisinopril	306	79
Pantoprazole Sodium	Pantoprazole Sodium	295	67
Omeprazole	Omeprazole	294	73
Losartan Potassium	Losartan Potassium	293	65
Metformin Hcl	Metformin Hcl	293	69
Famotidine	Famotidine	239	49
Duloxetine Hcl	Duloxetine Hcl	232	38
Trazodone Hcl	Trazodone Hcl	226	42
Simvastatin	Simvastatin	218	61
Albuterol Sulfate Hfa	Albuterol Sulfate	202	59
Furosemide	Furosemide	182	40
Potassium Chloride	Potassium Chloride	155	34
Escitalopram Oxalate	Escitalopram Oxalate	152	35
Fluticasone Propionate	Fluticasone Propionate	150	44
Myrbetriq	Mirabegron	145	19
Tizanidine Hcl	Tizanidine Hcl	143	42
Eliquis	Apixaban	139	28
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	133	29
Carvedilol	Carvedilol	132	22
Hydrochlorothiazide	Hydrochlorothiazide	125	25
Tamsulosin Hcl	Tamsulosin Hcl	118	29
Ropinirole Hcl	Ropinirole Hcl	114	22
Tramadol Hcl	Tramadol Hcl	114	19
Ozempic	Semaglutide	112	21
Alendronate Sodium	Alendronate Sodium	106	26
Rosuvastatin Calcium	Rosuvastatin Calcium	106	24
Allopurinol	Allopurinol	104	25
Metoprolol Tartrate	Metoprolol Tartrate	104	26
Sertraline Hcl	Sertraline Hcl	96	14
Glimepiride	Glimepiride	95	23
Montelukast Sodium	Montelukast Sodium	88	19
Jardiance	Empagliflozin	87	18
Metoprolol Succinate	Metoprolol Succinate	86	23
Citalopram Hbr	Citalopram Hydrobromide	85	19
Venlafaxine Hcl Er	Venlafaxine Hcl	83	13
Meloxicam	Meloxicam	81	25
Clopidogrel	Clopidogrel Bisulfate	76	20
Pravastatin Sodium	Pravastatin Sodium	76	18
Pregabalin	Pregabalin	75	15
Farxiga	Dapagliflozin Propanediol	72	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	67	24
Chlorthalidone	Chlorthalidone	66	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	64	17
Tradjenta	Linagliptin	63	11
Alprazolam	Alprazolam	60	suppressed
Lorazepam	Lorazepam	54	13
Ondansetron Hcl	Ondansetron Hcl	53	14
Ventolin Hfa	Albuterol Sulfate	52	13
Clonazepam	Clonazepam	51	suppressed
Mounjaro	Tirzepatide	48	suppressed
Aripiprazole	Aripiprazole	47	11
Pioglitazone Hcl	Pioglitazone Hcl	46	suppressed
Diclofenac Sodium	Diclofenac Sodium	45	15
Ezetimibe	Ezetimibe	45	suppressed
Trulicity	Dulaglutide	45	suppressed
Celecoxib	Celecoxib	44	suppressed
Donepezil Hcl	Donepezil Hcl	44	suppressed
Cephalexin	Cephalexin	43	36
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	43	suppressed
Hydralazine Hcl	Hydralazine Hcl	43	14
Spironolactone	Spironolactone	43	13
Sucralfate	Sucralfate	43	15
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	41	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	40	13
Paroxetine Hcl	Paroxetine Hcl	40	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	39	suppressed
Mirtazapine	Mirtazapine	39	suppressed
Symbicort	Budesonide/Formoterol Fumarate	39	suppressed
Prednisone	Prednisone	38	26
Propranolol Hcl	Propranolol Hcl	38	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	38	suppressed
Temazepam	Temazepam	38	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	37	suppressed
Testosterone Cypionate	Testosterone Cypionate	37	suppressed
Valacyclovir	Valacyclovir Hcl	37	11
Bupropion Hcl Sr	Bupropion Hcl	35	11
Oxybutynin Chloride	Oxybutynin Chloride	35	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	34	suppressed
Nystatin	Nystatin	34	16
Azelastine Hcl	Azelastine Hcl	32	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	30	suppressed
Mupirocin	Mupirocin	30	25
Novolog Flexpen	Insulin Aspart	30	suppressed
Synthroid	Levothyroxine Sodium	30	suppressed
Solifenacin Succinate	Solifenacin Succinate	29	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	29	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	28	25
Ibuprofen	Ibuprofen	26	suppressed
Xarelto	Rivaroxaban	26	suppressed
Fenofibrate	Fenofibrate	24	suppressed
Linzess	Linaclotide	24	suppressed
Metformin Hcl Er	Metformin Hcl	24	suppressed
Baclofen	Baclofen	23	suppressed
Tresiba Flextouch U-100	Insulin Degludec	23	suppressed
Bupropion Xl	Bupropion Hcl	22	suppressed
Dutasteride	Dutasteride	22	suppressed
Vraylar	Cariprazine Hcl	22	suppressed
Warfarin Sodium	Warfarin Sodium	22	suppressed
Doxepin Hcl	Doxepin Hcl	21	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	21	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	21	suppressed
Trimethoprim	Trimethoprim	21	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	20	suppressed
Diazepam	Diazepam	20	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	20	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	19	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	19	suppressed
Enalapril Maleate	Enalapril Maleate	18	suppressed
Finasteride	Finasteride	17	suppressed
Januvia	Sitagliptin Phosphate	17	suppressed
Risperidone	Risperidone	17	suppressed
Buspirone Hcl	Buspirone Hcl	16	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Glipizide Er	Glipizide	16	suppressed
Oxcarbazepine	Oxcarbazepine	16	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	16	14
Promethazine Hcl	Promethazine Hcl	15	suppressed
Topiramate	Topiramate	15	suppressed
Colestipol Hcl	Colestipol Hcl	14	suppressed
Cyproheptadine Hcl	Cyproheptadine Hcl	14	suppressed
Desloratadine	Desloratadine	14	suppressed
Lubiprostone	Lubiprostone	14	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Methylprednisolone	Methylprednisolone	14	14
Naproxen	Naproxen	14	suppressed
Primidone	Primidone	14	suppressed
Spiriva Respimat	Tiotropium Bromide	14	suppressed
Benazepril Hcl	Benazepril Hcl	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Ibu	Ibuprofen	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	13	suppressed
Varenicline Tartrate	Varenicline Tartrate	13	suppressed
Vascepa	Icosapent Ethyl	13	suppressed
Alogliptin	Alogliptin Benzoate	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	11
Azithromycin	Azithromycin	12	suppressed
Bupropion Hcl	Bupropion Hcl	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	12	suppressed
Olanzapine	Olanzapine	12	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	12	suppressed
Brilinta	Ticagrelor	11	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	suppressed
Estradiol	Estradiol	11	suppressed
Gemfibrozil	Gemfibrozil	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Pentoxifylline	Pentoxifylline	11	suppressed
Phenobarbital	Phenobarbital	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error